TETRAULT LYNN A.

Average Profitability
1.24%
Insider Buys Quantity
2
Insider Buys Sum
$210,030.00
Insider Sells Quantity
7
Insider Sells Sum
$2.37M

Insider Activity of TETRAULT LYNN A.

According to the SEC Form 4 filings, TETRAULT LYNN A., being in a position of

  1. director at NeoGenomics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 6112 shares for $97,579,
    over all time since 2015-12-07, has bought 26000 shares for $210,030, and sold 42112 shares for $675,059.

The largest purchase of all time was on 2015-12-21 and amounted to 19000 shares of NeoGenomics, Inc. for $155,990.

The largest sale of all time was on 2024-09-10 and amounted to 17501 share of Rhythm Pharmaceuticals, Inc. for $868,923.

Biography of TETRAULT LYNN A.

No biography is available at this moment.

2024-09-10SaleRhythm Pharmaceuticals, Inc.
RYTM
director
17,501
0.029%
$49.65$868,923+2.29%
2024-09-09SaleRhythm Pharmaceuticals, Inc.
RYTM
director
3,199
0.0052%
$50.04$160,068-0.93%
2024-08-26SaleRhythm Pharmaceuticals, Inc.
RYTM
director
4,300
0.007%
$50.01$215,029-0.84%
2024-08-12SaleRhythm Pharmaceuticals, Inc.
RYTM
director
10,000
0.0165%
$44.65$446,462+11.35%
2024-03-04SaleNeoGenomics, Inc.
NEO
director
6,112
0.0048%
$15.97$97,579-8.03%
2018-11-19SaleNeoGenomics, Inc.
NEO
director
26,000
0.0277%
$16.00$415,880+29.73%
2018-11-14SaleNeoGenomics, Inc.
NEO
director
10,000
0.0108%
$16.16$161,600+29.56%
2015-12-21PurchaseNeoGenomics, Inc.
NEO
director
19,000
0.0313%
$8.21$155,990-2.06%
2015-12-07PurchaseNeoGenomics, Inc.
NEO
director
7,000
0.0116%
$7.72$54,040+4.55%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.